The Translational Core is designed to support CRDD projects by collecting and supplying well characterized specimens from humans, domestic animals and wildlife with infectious diseases, and providing access to CLIA laboratories at the New York State Department of Health Wadsworth Center (NYSDOHWC) and New York City Department of Health and Mental Hygiene (NYCDOHMH) that are staffed with public health personnel who have specific expertise in optimizing and validating diagnostic assays for clinical use. All CRDD projects?whether focused on direct detection of microbial genomic targets or of host transcripts or antibodies that provide indirect evidence of infection and of insights into host response?require specimens for discovery and diagnostic assay development and validation. Through membership in regional, national and global laboratory networks, Translational Core investigators Christina Egan (NYSDOHWC), William Karesh (EcoHealth Alliance), Lipkin (Cll) and Jay Varma (NYCDOHMH) enjoy unique access to a wide range of samples and isolates to support discovery and diagnostic aims. Application of new clinical assays requires validation using specific criteria and diverse specimen matrices. In New York State, assays must be validated by the NYSDOHWC. The validation application and approval process is comprehensive and comparable to and supportive of moving the assay through the FDA approval process. By engaging NYSDOHWC and NYCDOHMH from the outset, the Translational Core is poised to expedite translation of basic research in diagnostics into products that will be used in public health and clinical laboratories and enhance the prospects for commercialization.

Public Health Relevance

The Translational Core provides samples required for CRDD research projects as well as support for optimization and validation of diagnostic assays in the central clinical laboratories of the New York State Department of Health Wadsworth Center and the New York City Department of Health and Mental Hygiene. These functions will expedite the development and implementation of diagnostic tests that reduce the morbidity, mortality and economic costs of infectious diseases

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI109761-01
Application #
8655289
Study Section
Special Emphasis Panel (ZAI1-LR-M (J1))
Project Start
Project End
Budget Start
2014-03-07
Budget End
2015-02-28
Support Year
1
Fiscal Year
2014
Total Cost
$826,333
Indirect Cost
$158,637
Name
Columbia University
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Morrison, Juliet; Rathore, Abhay P S; Mantri, Chinmay K et al. (2017) Transcriptional Profiling Confirms the Therapeutic Effects of Mast Cell Stabilization in a Dengue Disease Model. J Virol 91:
Hertz, Tomer; Beatty, P Robert; MacMillen, Zachary et al. (2017) Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections. J Immunol 198:4025-4035
Johansen, Cheryl A; Williams, Simon H; Melville, Lorna F et al. (2017) Characterization of Fitzroy River Virus and Serologic Evidence of Human and Animal Infection. Emerg Infect Dis 23:1289-1299
Menachery, Vineet D; Graham, Rachel L; Baric, Ralph S (2017) Jumping species-a mechanism for coronavirus persistence and survival. Curr Opin Virol 23:1-7
Hou, Yixuan; Lin, Chun-Ming; Yokoyama, Masaru et al. (2017) Deletion of a 197-Amino-Acid Region in the N-Terminal Domain of Spike Protein Attenuates Porcine Epidemic Diarrhea Virus in Piglets. J Virol 91:
Lindesmith, Lisa C; Kocher, Jacob F; Donaldson, Eric F et al. (2017) Emergence of Novel Human Norovirus GII.17 Strains Correlates With Changes in Blockade Antibody Epitopes. J Infect Dis 216:1227-1234
Lindesmith, Lisa C; Brewer-Jensen, Paul D; Mallory, Michael L et al. (2017) Antigenic characterization of a novel recombinant GII.P16-GII.4 Sydney norovirus strain with minor sequence variation leading to antibody escape. J Infect Dis :
Wang, Jiaqi; Bardelli, Marco; Espinosa, Diego A et al. (2017) A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential. Cell 171:229-241.e15
Sheahan, Timothy P; Sims, Amy C; Graham, Rachel L et al. (2017) Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med 9:
Dutta, Mukta; Robertson, Shelly J; Okumura, Atsushi et al. (2017) A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection. Cell Rep 18:816-829

Showing the most recent 10 out of 54 publications